Lista de obras -

5-HT2C Agonists Modulate Schizophrenia-Like Behaviors in Mice.

artículo científico publicado en 2017

759C/T genetic variation of 5HT(2C) receptor and clozapine-induced weight gain

artículo científico publicado en 2002

A common polymorphism in the cannabinoid receptor 1 (CNR1) gene is associated with antipsychotic-induced weight gain in Schizophrenia

artículo científico publicado en 2010

A genome-wide investigation of SNPs and CNVs in schizophrenia

artículo científico publicado en 2009

A hypothesis-driven association study of 28 nuclear-encoded mitochondrial genes with antipsychotic-induced weight gain in schizophrenia

artículo científico publicado en 2013

A mouse model of human primitive neuroectodermal tumors resulting from microenvironmentally-driven malignant transformation of orthotopically transplanted radial glial cells

artículo científico publicado en 2015

A randomized, double-blind, placebo-controlled trial of aripiprazole lauroxil in acute exacerbation of schizophrenia

artículo científico publicado en 2015

A within-subject consideration of the psychotic spectrum disorder concept in a patient in remission associated with cortical gray matter recovery

artículo científico publicado en 2018

Activation of Dopamine Receptor 2 Prompts Transcriptomic and Metabolic Plasticity in Glioblastoma

scientific article published on 16 January 2019

Amisulpride is a potent 5-HT7 antagonist: relevance for antidepressant actions in vivo

artículo científico publicado en 2009

An unstable trinucleotide-repeat region on chromosome 13 implicated in spinocerebellar ataxia: a common expansion locus

artículo científico publicado en 2000

Association Study of Serotonin 3 Receptor Subunit Gene Variants in Antipsychotic-Induced Weight Gain

artículo científico publicado en 2017

Association between common variants near the melanocortin 4 receptor gene and severe antipsychotic drug-induced weight gain

artículo científico publicado en 2012

Association between the -2548G/A polymorphism of the leptin gene and antipsychotic-induced weight gain: Analysis of the CATIE sample and meta-analysis

scientific article published on 23 April 2020

Association of FAS, a TNF-α receptor gene, with treatment resistant schizophrenia

artículo científico publicado en 2011

Association of a functional polymorphism in neuropeptide Y with antipsychotic-induced weight gain in schizophrenia patients.

artículo científico publicado en 2013

Association of orexin receptor polymorphisms with antipsychotic-induced weight gain

artículo científico publicado en 2015

Association of the MscI polymorphism of the dopamine D3 receptor gene with tardive dyskinesia in schizophrenia

artículo científico publicado en 1999

Association of the alpha 2A adrenergic receptor -1291C/G polymorphism and antipsychotic-induced weight gain in European-Americans.

artículo científico publicado en 2009

Association of the orphan nuclear receptor NR4A1 with tardive dyskinesia

artículo científico publicado en 2010

Association study between a functional glutathione S-transferase (GSTP1) gene polymorphism (Ile105Val) and tardive dyskinesia

artículo científico publicado en 2005

Association study between the neurexin-1 gene and tardive dyskinesia

artículo científico publicado en 2017

Association study between variants of AMP-activated protein kinase catalytic and regulatory subunit genes with antipsychotic-induced weight gain

artículo científico publicado en 2012

Association study of 12 polymorphisms spanning the dopamine D(2) receptor gene and clozapine treatment response in two treatment refractory/intolerant populations

artículo científico publicado en 2005

Association study of BDNF and DRD3 genes in schizophrenia diagnosis using matched case-control and family based study designs.

artículo científico publicado en 2010

Association study of Disrupted-In-Schizophrenia-1 gene variants and tardive dyskinesia

scientific article published on 15 August 2018

Association study of GABAA α2 receptor subunit gene variants in antipsychotic-associated weight gain

artículo científico publicado en 2015

Association study of GRIK1 gene polymorphisms in schizophrenia: case-control and family-based studies

artículo científico publicado en 2012

Association study of GSK3 gene polymorphisms with schizophrenia and clozapine response

artículo científico publicado en 2008

Association study of four dopamine D1 receptor gene polymorphisms and clozapine treatment response

artículo científico publicado en 2006

Association study of polymorphisms in cholecystokinin gene and its receptors with antipsychotic induced weight gain in schizophrenia patients

artículo científico publicado en 2010

Association study of polymorphisms in insulin induced gene 2 (INSIG2) with antipsychotic-induced weight gain in European and African-American schizophrenia patients

artículo científico publicado en 2010

Association study of tardive dyskinesia and twelve DRD2 polymorphisms in schizophrenia patients

artículo científico publicado en 2006

Association study of the GSK-3B gene with tardive dyskinesia in European Caucasians

artículo científico publicado en 2010

Association study of the gamma-aminobutyric acid type a receptor gamma2 subunit gene with schizophrenia

artículo científico publicado en 2009

Association study of the vesicular monoamine transporter gene SLC18A2 with tardive dyskinesia

artículo científico publicado en 2013

Atypical, but not typical, antipsychotic drugs increase cortical acetylcholine release without an effect in the nucleus accumbens or striatum

artículo científico publicado en 2002

Catechol-O-Methyltransferase Val158Met Polymorphism and Clinical Response to Antipsychotic Treatment in Schizophrenia and Schizo-Affective Disorder Patients: a Meta-Analysis

artículo científico publicado en 2016

Clozapine acts as an agonist at serotonin 2A receptors to counter MK-801-induced behaviors through a βarrestin2-independent activation of Akt

artículo científico publicado en 2014

Combined analysis of 635 patients confirms an age-related association of the serotonin 2A receptor gene with tardive dyskinesia and specificity for the non-orofacial subtype

artículo científico publicado en 2005

Common variants conferring risk of schizophrenia: a pathway analysis of GWAS data

artículo científico publicado en 2010

Correction: A Genome-Wide Investigation of SNPs and CNVs in Schizophrenia

Dopamine D2 receptor gene variants and quantitative measures of positive and negative symptom response following clozapine treatment

artículo científico publicado en 2005

Dopamine D4 and D5 receptor gene variant effects on clozapine response in schizophrenia: replication and exploration

artículo científico publicado en 2011

Evidence for a SULT4A1 haplotype correlating with baseline psychopathology and atypical antipsychotic response

artículo científico publicado en 2011

Exome sequencing followed by large-scale genotyping suggests a limited role for moderately rare risk factors of strong effect in schizophrenia

artículo científico publicado en 2012

Exploratory study on association of genetic variation in TBC1D1 with antipsychotic-induced weight gain

artículo científico publicado en 2013

F1. GENOME-WIDE ASSOCIATION STUDIES SUGGESTED ASSOCIATION BETWEEN DGKB AND ANTIPSYCHOTIC INDUCED WEIGHT GAIN IN EUROPEANS AND AFRICAN AMERICANS.

artículo científico publicado en 2018

Family and case-control association study of the tumor necrosis factor-alpha (TNF-alpha) gene with schizophrenia and response to antipsychotic medication.

artículo científico publicado en 2006

Fat mass- and obesity-associated (FTO) gene and antipsychotic-induced weight gain: an association study

artículo científico publicado en 2014

Feasibility, efficacy, and safety of antipsychotics for intensive care unit delirium: the MIND randomized, placebo-controlled trial

artículo científico publicado en 2010

Finite mixture regression model analysis on antipsychotics induced weight gain: investigation of the role of the serotonergic genes

artículo científico publicado en 2012

Gamma-Aminobutyric Acidergic Projections From the Dorsal Raphe to the Nucleus Accumbens Are Regulated by Neuromedin U.

artículo científico publicado en 2016

Genetic association analysis of N-methyl-D-aspartate receptor subunit gene GRIN2B and clinical response to clozapine

artículo científico publicado en 2016

Genetic association analysis of the glutathione peroxidase (GPX1) gene polymorphism (Pro197Leu) with tardive dyskinesia

artículo científico publicado en 2006

Genetic association of the GDNF alpha-receptor genes with schizophrenia and clozapine response.

artículo científico publicado en 2010

Genetic interactions in the adrenergic system genes: analysis of antipsychotic-induced weight gain

artículo científico publicado en 2011

Genetic predictors of antipsychotic response to lurasidone identified in a genome wide association study and by schizophrenia risk genes

artículo científico publicado en 2017

Genetic study of BDNF, DRD3, and their interaction in tardive dyskinesia

artículo científico publicado en 2009

Genetic study of eight AKT1 gene polymorphisms and their interaction with DRD2 gene polymorphisms in tardive dyskinesia

artículo científico publicado en 2008

Genetic study of neuregulin 1 and receptor tyrosine-protein kinase erbB-4 in tardive dyskinesia

artículo científico publicado en 2017

Genetic validation study of protein tyrosine phosphatase receptor type D (PTPRD) gene variants and risk for antipsychotic-induced weight gain

artículo científico publicado en 2018

Genetic variation in CYP3A43 is associated with response to antipsychotic medication

artículo científico publicado en 2014

Genetic variation in the GCG and in the GLP1R genes and antipsychotic-induced weight gain

artículo científico publicado en 2014

Genome-wide association study on antipsychotic-induced weight gain in Europeans and African-Americans

artículo científico publicado en 2019

Glial cell line-derived neurotrophic factor receptor alpha 2 (GFRA2) gene is associated with tardive dyskinesia.

artículo científico publicado en 2010

H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs.

artículo científico publicado en 2003

HTR2C haplotypes and antipsychotics-induced weight gain: X-linked multimarker analysis

artículo científico publicado en 2007

Identification of the role of bone morphogenetic protein (BMP) and transforming growth factor-β (TGF-β) signaling in the trajectory of serotonergic differentiation in a rapid assay in mouse embryonic stem cells in vitro.

artículo científico publicado en 2015

Impact of histamine receptors H1 and H3 polymorphisms on antipsychotic-induced weight gain

artículo científico publicado en 2016

In vivo actions of atypical antipsychotic drug on serotonergic and dopaminergic systems

artículo científico publicado en 2008

Influence of neurexin 1 (NRXN1) polymorphisms in clozapine response.

artículo científico publicado en 2010

Influence of serotonin 3A and 3B receptor genes on clozapine treatment response in schizophrenia

artículo científico publicado en 2010

Investigation of TSPO variants in schizophrenia and antipsychotic treatment outcomes

artículo científico publicado en 2015

Investigation of melanocortin system gene variants in antipsychotic-induced weight gain

artículo científico publicado en 2014

Investigation of the Gene in Tardive Dyskinesia - New Data and Meta-Analysis

article

It is time to take a stand for medical research and against terrorism targeting medical scientists

artículo científico publicado en 2008

Lack of association between HTR4 gene polymorphisms and schizophrenia in case-control and family-based samples

artículo científico publicado en 2009

Lack of association between serotonin-2A receptor gene (HTR2A) polymorphisms and tardive dyskinesia in schizophrenia

artículo científico publicado en 2001

Lack of association of GPX1 and MnSOD genes with symptom severity and response to clozapine treatment in schizophrenia subjects

artículo científico publicado en 2009

Lack of association of NALCN genetic variants with schizophrenia.

artículo científico publicado en 2010

Liver enzyme CYP2D6 gene and tardive dyskinesia

scientific article published on 24 September 2020

Lorcaserin and pimavanserin: emerging selectivity of serotonin receptor subtype-targeted drugs

artículo científico

MDR1 gene in tardive dyskinesia scale scores: comparison of strategies for quantitative trait haplotype analysis.

artículo científico publicado en 2009

New insights into tardive dyskinesia genetics: Implementation of whole-exome sequencing approach

artículo científico publicado en 2019

No association of the T102C polymorphism of the serotonin 2A receptor gene (HTR2A) with suicidality in schizophrenia

artículo científico publicado en 2004

No evidence for a role of the peroxisome proliferator-activated receptor gamma (PPARG) and adiponectin (ADIPOQ) genes in antipsychotic-induced weight gain

artículo científico publicado en 2014

Oxidative stress in tardive dyskinesia: genetic association study and meta-analysis of NADPH quinine oxidoreductase 1 (NQO1) and Superoxide dismutase 2 (SOD2, MnSOD) genes

artículo científico publicado en 2009

PM389. Preliminary Genetic Model Predicting Clozapine Response.

artículo científico publicado en 2016

Pathway-based analysis of GWAS datasets: effective but caution required ⬇️

artículo científico publicado el 16 de diciembre de 2010

Pharmacogenetic Analysis of Functional Glutamate System Gene Variants and Clinical Response to Clozapine

artículo científico publicado en 2016

Pharmacogenetics of tardive dyskinesia: combined analysis of 780 patients supports association with dopamine D3 receptor gene Ser9Gly polymorphism

artículo científico publicado en 2002

Phosphodiesterase 4B genetic variants are not associated with antipsychotic-induced tardive dyskinesia

artículo científico publicado en 2010

Polymorphisms of the HTR2C gene and antipsychotic-induced weight gain: an update and meta-analysis

artículo científico publicado en 2010

Preliminary evidence for association of genome-wide significant DRD2 schizophrenia risk variant with clozapine response

artículo científico publicado en 2015

Prolactin as a biomarker for treatment response and tardive dyskinesia in schizophrenia subjects: old thoughts revisited from a genetic perspective.

artículo científico publicado en 2011

Protein kinase cAMP-dependent regulatory type II beta (PRKAR2B) gene variants in antipsychotic-induced weight gain.

artículo científico publicado en 2014

Randomized controlled trial of deutetrabenazine for tardive dyskinesia: The ARM-TD study

artículo científico publicado en 2017

Role of ethnicity in antipsychotic-induced weight gain and tardive dyskinesia: genes or environment?

artículo científico publicado en 2013

SU3. Preliminary Study for Association of Genome-Wide Significant Glutamate Receptor Schizophrenia Risk Variants With Clozapine Response.

artículo científico publicado en 2017

Schizophrenia severity and clozapine treatment outcome association with oxytocinergic genes

artículo científico publicado en 2010

Schizophrenia-associated gene dysbindin-1 and tardive dyskinesia

scientific article published on 11 May 2020

Subchronic phencyclidine treatment in adult mice increases GABAergic transmission and LTP threshold in the hippocampus.

artículo científico publicado en 2015

Suggestive association between the C825T polymorphism of the G-protein beta3 subunit gene (GNB3) and clinical improvement with antipsychotics in schizophrenia

artículo científico publicado en 2005

Suicidality and risk of suicide--definition, drug safety concerns, and a necessary target for drug development: a brief report

artículo científico publicado en 2010

Suicidality and risk of suicide--definition, drug safety concerns, and a necessary target for drug development: a consensus statement

artículo científico publicado en 2010

Sulfotransferase 4A1 Haplotype 1 (SULT4A1-1) Is Associated With Decreased Hospitalization Events in Antipsychotic-Treated Patients With Schizophrenia

artículo científico publicado en 2012

T7. PHARMACOGENETIC OF TARDIVE DYSKINESIA -- A FOLLOW-UP ON THE VALBENAZINE TARGET VMAT2/SLC18A2.

artículo científico publicado en 2018

The catechol-O-methyl-transferase gene in tardive dyskinesia

artículo científico publicado en 2010

The effect of high vs. low dose lurasidone on eye movement biomarkers of prefrontal abilities in treatment-resistant schizophrenia

scientific article published on 06 November 2019

The highly efficacious actions of N-desmethylclozapine at muscarinic receptors are unique and not a common property of either typical or atypical antipsychotic drugs: is M1 agonism a pre-requisite for mimicking clozapine's actions?

artículo científico publicado en 2004

The neurotensin analog NT69L enhances medial prefrontal cortical dopamine and acetylcholine efflux: potentiation of risperidone-, but not haloperidol-, induced dopamine efflux

artículo científico publicado en 2007

The putative functional rs1045881 marker of neurexin-1 in schizophrenia and clozapine response

artículo científico publicado en 2011

The role of brain-derived neurotrophic factor (BDNF) gene variants in antipsychotic response and antipsychotic-induced weight gain

artículo científico publicado en 2012

The role of genetic variation across IL-1β, IL-2, IL-6, and BDNF in antipsychotic-induced weight gain

artículo científico publicado en 2015

Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology

artículo científico publicado en 2016

Variants in the oxytocin gene and risk for schizophrenia

artículo científico publicado en 2010

WAY-163909 [(7bR,10aR)-1,2,3,4,8,9,10,10a-octahydro-7bH-cyclopenta-[b][1,4]diazepino[6,7,1hi]indole]: A novel 5-hydroxytryptamine 2C receptor-selective agonist with preclinical antipsychotic-like activity

artículo científico publicado en 2006

Ziprasidone : a viewpoint by herbert y. Meltzer

artículo científico publicado en 1997

Lista de obras de

5-HT2C Agonists Modulate Schizophrenia-Like Behaviors in Mice.

759C/T genetic variation of 5HT(2C) receptor and clozapine-induced weight gain

A common polymorphism in the cannabinoid receptor 1 (CNR1) gene is associated with antipsychotic-induced weight gain in Schizophrenia

A genome-wide investigation of SNPs and CNVs in schizophrenia

A hypothesis-driven association study of 28 nuclear-encoded mitochondrial genes with antipsychotic-induced weight gain in schizophrenia

A mouse model of human primitive neuroectodermal tumors resulting from microenvironmentally-driven malignant transformation of orthotopically transplanted radial glial cells

A randomized, double-blind, placebo-controlled trial of aripiprazole lauroxil in acute exacerbation of schizophrenia

A within-subject consideration of the psychotic spectrum disorder concept in a patient in remission associated with cortical gray matter recovery

Activation of Dopamine Receptor 2 Prompts Transcriptomic and Metabolic Plasticity in Glioblastoma

Amisulpride is a potent 5-HT7 antagonist: relevance for antidepressant actions in vivo

An unstable trinucleotide-repeat region on chromosome 13 implicated in spinocerebellar ataxia: a common expansion locus

Association Study of Serotonin 3 Receptor Subunit Gene Variants in Antipsychotic-Induced Weight Gain

Association between common variants near the melanocortin 4 receptor gene and severe antipsychotic drug-induced weight gain

Association between the -2548G/A polymorphism of the leptin gene and antipsychotic-induced weight gain: Analysis of the CATIE sample and meta-analysis

Association of FAS, a TNF-α receptor gene, with treatment resistant schizophrenia

Association of a functional polymorphism in neuropeptide Y with antipsychotic-induced weight gain in schizophrenia patients.

Association of orexin receptor polymorphisms with antipsychotic-induced weight gain

Association of the MscI polymorphism of the dopamine D3 receptor gene with tardive dyskinesia in schizophrenia

Association of the alpha 2A adrenergic receptor -1291C/G polymorphism and antipsychotic-induced weight gain in European-Americans.

Association of the orphan nuclear receptor NR4A1 with tardive dyskinesia

Association study between a functional glutathione S-transferase (GSTP1) gene polymorphism (Ile105Val) and tardive dyskinesia

Association study between the neurexin-1 gene and tardive dyskinesia

Association study between variants of AMP-activated protein kinase catalytic and regulatory subunit genes with antipsychotic-induced weight gain

Association study of 12 polymorphisms spanning the dopamine D(2) receptor gene and clozapine treatment response in two treatment refractory/intolerant populations

Association study of BDNF and DRD3 genes in schizophrenia diagnosis using matched case-control and family based study designs.

Association study of Disrupted-In-Schizophrenia-1 gene variants and tardive dyskinesia

Association study of GABAA α2 receptor subunit gene variants in antipsychotic-associated weight gain

Association study of GRIK1 gene polymorphisms in schizophrenia: case-control and family-based studies

Association study of GSK3 gene polymorphisms with schizophrenia and clozapine response

Association study of four dopamine D1 receptor gene polymorphisms and clozapine treatment response

Association study of polymorphisms in cholecystokinin gene and its receptors with antipsychotic induced weight gain in schizophrenia patients

Association study of polymorphisms in insulin induced gene 2 (INSIG2) with antipsychotic-induced weight gain in European and African-American schizophrenia patients

Association study of tardive dyskinesia and twelve DRD2 polymorphisms in schizophrenia patients

Association study of the GSK-3B gene with tardive dyskinesia in European Caucasians

Association study of the gamma-aminobutyric acid type a receptor gamma2 subunit gene with schizophrenia

Association study of the vesicular monoamine transporter gene SLC18A2 with tardive dyskinesia

Atypical, but not typical, antipsychotic drugs increase cortical acetylcholine release without an effect in the nucleus accumbens or striatum

Catechol-O-Methyltransferase Val158Met Polymorphism and Clinical Response to Antipsychotic Treatment in Schizophrenia and Schizo-Affective Disorder Patients: a Meta-Analysis

Clozapine acts as an agonist at serotonin 2A receptors to counter MK-801-induced behaviors through a βarrestin2-independent activation of Akt

Combined analysis of 635 patients confirms an age-related association of the serotonin 2A receptor gene with tardive dyskinesia and specificity for the non-orofacial subtype

Common variants conferring risk of schizophrenia: a pathway analysis of GWAS data

Correction: A Genome-Wide Investigation of SNPs and CNVs in Schizophrenia

Dopamine D2 receptor gene variants and quantitative measures of positive and negative symptom response following clozapine treatment

Dopamine D4 and D5 receptor gene variant effects on clozapine response in schizophrenia: replication and exploration

Evidence for a SULT4A1 haplotype correlating with baseline psychopathology and atypical antipsychotic response

Exome sequencing followed by large-scale genotyping suggests a limited role for moderately rare risk factors of strong effect in schizophrenia

Exploratory study on association of genetic variation in TBC1D1 with antipsychotic-induced weight gain

F1. GENOME-WIDE ASSOCIATION STUDIES SUGGESTED ASSOCIATION BETWEEN DGKB AND ANTIPSYCHOTIC INDUCED WEIGHT GAIN IN EUROPEANS AND AFRICAN AMERICANS.

Family and case-control association study of the tumor necrosis factor-alpha (TNF-alpha) gene with schizophrenia and response to antipsychotic medication.

Fat mass- and obesity-associated (FTO) gene and antipsychotic-induced weight gain: an association study

Feasibility, efficacy, and safety of antipsychotics for intensive care unit delirium: the MIND randomized, placebo-controlled trial

Finite mixture regression model analysis on antipsychotics induced weight gain: investigation of the role of the serotonergic genes

Gamma-Aminobutyric Acidergic Projections From the Dorsal Raphe to the Nucleus Accumbens Are Regulated by Neuromedin U.

Genetic association analysis of N-methyl-D-aspartate receptor subunit gene GRIN2B and clinical response to clozapine

Genetic association analysis of the glutathione peroxidase (GPX1) gene polymorphism (Pro197Leu) with tardive dyskinesia

Genetic association of the GDNF alpha-receptor genes with schizophrenia and clozapine response.

Genetic interactions in the adrenergic system genes: analysis of antipsychotic-induced weight gain

Genetic predictors of antipsychotic response to lurasidone identified in a genome wide association study and by schizophrenia risk genes

Genetic study of BDNF, DRD3, and their interaction in tardive dyskinesia

Genetic study of eight AKT1 gene polymorphisms and their interaction with DRD2 gene polymorphisms in tardive dyskinesia

Genetic study of neuregulin 1 and receptor tyrosine-protein kinase erbB-4 in tardive dyskinesia

Genetic validation study of protein tyrosine phosphatase receptor type D (PTPRD) gene variants and risk for antipsychotic-induced weight gain

Genetic variation in CYP3A43 is associated with response to antipsychotic medication

Genetic variation in the GCG and in the GLP1R genes and antipsychotic-induced weight gain

Genome-wide association study on antipsychotic-induced weight gain in Europeans and African-Americans

Glial cell line-derived neurotrophic factor receptor alpha 2 (GFRA2) gene is associated with tardive dyskinesia.

H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs.

HTR2C haplotypes and antipsychotics-induced weight gain: X-linked multimarker analysis

Identification of the role of bone morphogenetic protein (BMP) and transforming growth factor-β (TGF-β) signaling in the trajectory of serotonergic differentiation in a rapid assay in mouse embryonic stem cells in vitro.

Impact of histamine receptors H1 and H3 polymorphisms on antipsychotic-induced weight gain

In vivo actions of atypical antipsychotic drug on serotonergic and dopaminergic systems

Influence of neurexin 1 (NRXN1) polymorphisms in clozapine response.

Influence of serotonin 3A and 3B receptor genes on clozapine treatment response in schizophrenia

Investigation of TSPO variants in schizophrenia and antipsychotic treatment outcomes

Investigation of melanocortin system gene variants in antipsychotic-induced weight gain

Investigation of the Gene in Tardive Dyskinesia - New Data and Meta-Analysis

It is time to take a stand for medical research and against terrorism targeting medical scientists

Lack of association between HTR4 gene polymorphisms and schizophrenia in case-control and family-based samples

Lack of association between serotonin-2A receptor gene (HTR2A) polymorphisms and tardive dyskinesia in schizophrenia